CTRI/2023/09/057654尚未招募Unknown
Role of Bromocriptine in Peripartum Cardiomyopathy: A Randomized Controlled Study in a Tertiary Care Centre of North India
ICMR0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Women who will be diagnosed as having PPCM with ejection fraction =35%
排除标准
- •Clinical conditions other than cardiomyopathy that could increase plasma levels of inflammatory markers such as sepsis, autoimmune disease, or HIV positivity
- •Any thrombogenic condition
- •Severe peptic ulcer disease
研究者
相似试验
撤回
3 期
Bromocriptine in the Treatment of Peripartum CardiomyopathyPeripartum CardiomyopathyNCT02590601Montreal Heart Institute
招募中
4 期
Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyPeripartum Cardiomyopathy, PostpartumNCT05180773Dennis M. McNamara, MD, MS250
尚未招募
4 期
The Effect of vaginal Bromocriptine in controlling Adenomyosis symptomsACTRN12617001122347ahed ezzat allam68
招募中
3 期
Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive AgeDilated CardiomyopathyNCT06250257Jimma University112
尚未招募
不适用
Peripartum Cardiomyopathy Registry Biomarker sub-protocolPeripartum cardiomyopathypregnancy related heart failure1002859310010273NL-OMON43678European Society of Cardiology20